SAM Shorts Stay Put as Stock Jumps 12%

SAM enters its October 27 earnings report carrying the heaviest short position in its peer group, with bears showing no sign of retreat despite a sharp rally in the shares.

Short interest in Boston Beer stands at 19.1% of the free float, built up over a month in which the stock gained 20%. The position grew roughly 14% over the past 30 days, even as the stock climbed from around $168 to $202. Over the past week alone, SAM added 11.9%, more than double the peer median of around 4.9%. TAP gained 4.3% and STZ 5.6% over the same period. The divergence is large enough to rule out simple sector rotation.

The borrow market offers no pressure on those short positions. Availability is running at 404% of short interest, meaning roughly four shares are available to lend for every one already borrowed. That is up sharply from around 312% a week ago, so the pool is loosening, not tightening. Cost to borrow is 0.44%, slightly higher than a week ago but still effectively zero relative to the size of the bearish bet. With borrow this cheap and this plentiful, shorts face no mechanical cost pushing them to cover. The ORTEX short score has eased slightly to 65.3 from 67.3 at the start of the week, but remains elevated, ranking in the 7th percentile of the universe on a short-score basis.

The Street is broadly cautious. UBS raised its price target to $204 from $190 on Friday while keeping a Neutral rating. That target barely clears the current price of $202.28, leaving almost no implied upside even from the house that just lifted its number. Goldman Sachs carries a Sell rating with a $169 target, well below where the stock is trading. Most other recent moves have been target cuts: RBC lowered its number to $190 in early October, and Jefferies and Citigroup both trimmed targets in July. The mean analyst target is $198, fractionally below the current price. The PE ratio has expanded to 19.8x, up nearly 3 points over the past month, reflecting the stock re-rating faster than estimates have moved. EPS momentum ranks in the 20th to 22nd percentile on both 30-day and 90-day measures, a soft backdrop for a multiple expansion of this size.

The buyback programme has pulled back sharply. Boston Beer's Q2 2026 repurchase spend came to $26.6 million, down 49% from the same quarter a year earlier and the smallest Q2 buyback in two years. That removes one source of per-share support at exactly the point when the stock has become more expensive.

Options positioning has moved modestly more defensive into the print. The put/call ratio was 0.138 on Thursday, just under two standard deviations above its 20-day average of 0.127. The 52-week range on the PCR runs from 0.119 to 3.29, so the current reading is historically low in absolute terms, even with the recent uptick. Options traders are not panicking, but they have bought a little more protection this week than they had in recent weeks.

The earnings history adds one concrete data point. The most recent prior quarter produced an 11.3% next-day move. Before that, the July 2026 quarter generated a 1.9% move with a near-flat five-day follow-through. The pattern is inconsistent, which makes the directional call difficult to read from history alone. What the data shows clearly is that shorts are sitting on a significant position with cheap borrow, the stock has already moved sharply into the announcement, and the mean analyst target is below the current price.